Trial Evaluating the Efficacy of the Combination of ROpivacaine With Reference XYlocaine in the Evaluation of Pain During the Installation of Percutaneous Radiological GASTrostomy (GASTROXY)
Sponsor: Centre Hospitalier Universitaire de Saint Etienne
Terminated
Difficulties in recruiting patients
Other terminated trials from Centre Hospitalier Universitaire de Saint Etienne
- Healthy · Phase NA · Dec 2025
- Anorexia Nervosa · Phase NA · Jul 2025
- Hemodialysis Patients · Phase PHASE4 · Oct 2024
- Muscle Weakness · Phase NA · Aug 2024
- Muscle Spasticity · Phase NA · Jul 2024
See all terminations from Centre Hospitalier Universitaire de Saint Etienne
This PHASE2 trial investigates Cancer and Feeding Disorders and is currently terminated or withdrawn. Centre Hospitalier Universitaire de Saint Etienne leads this study, which shows 11 recorded versions since 2020 — indicating substantial longitudinal coverage. As an oncology study, it adds to the longitudinal record of treatment development for this indication.
Status Flow
Change History
11 versions recorded-
Sep 2024 — Present [monthly]
Terminated PHASE2
-
Jul 2024 — Sep 2024 [monthly]
Terminated PHASE2
-
Feb 2024 — Jul 2024 [monthly]
Terminated PHASE2
Status: Recruiting → Terminated
-
Jun 2023 — Feb 2024 [monthly]
Recruiting PHASE2
-
Mar 2022 — Jun 2023 [monthly]
Recruiting PHASE2
▶ Show 6 earlier versions
-
Jan 2021 — Mar 2022 [monthly]
Recruiting PHASE2
-
Nov 2020 — Jan 2021 [monthly]
Recruiting PHASE2
Status: Not Yet Recruiting → Recruiting
-
Sep 2020 — Nov 2020 [monthly]
Not Yet Recruiting PHASE2
-
Aug 2020 — Sep 2020 [monthly]
Not Yet Recruiting PHASE2
-
Mar 2020 — Aug 2020 [monthly]
Not Yet Recruiting PHASE2
-
Feb 2020 — Mar 2020 [monthly]
Not Yet Recruiting PHASE2
First recorded
Eligibility Summary
No eligibility information available.
Contact Information
- Centre Hospitalier Universitaire de Saint Etienne
- Institut de Cancérologie de la Loire
For direct contact, visit the study record on ClinicalTrials.gov .